Questions? Feedback? powered by Olark live chat software
All Site

ACEA’s xCELLigence Research Grant is aimed at helping early career scientists achieve their research goals by providing them free access to RTCA technology. This grant provides the winning scientist an xCELLigence RTCA DP instrument, consumables, and consultation for up to 6 months. ACEA is currently accepting xCELLigence Research Grant applications according to the schedule listed in the table below.

All entries must be received before the stated deadline in order to be considered.

Funding PeriodSubmissions Must Be Received ByInstrument
January-June 2019  December 8, 2018 xCELLigence RTCA DP



  1. Fill in the form to get access to the Application: ACEA’s xCELLigence RESEARCH GRANT 2017 Form

  2. Complete the application form

  3. Email the application form to 

Previous Grant Recipient

2018 Grant Recipient

Teresa KrabbeTERESA KRABBE, PhD student in the working group of Dr. Jennifer Altomonte, Klinikum Rechts der Isar of the Technical University Munich

Application: Oncolytic Viruses

Teresa Krabbe is awarded the xCELLigence Research Grant in December 2018 for her proposal to develop adoptive T cell therapy as a complimentary immunotherapeutic for an improved oncolytic virus platform.

“I am thrilled about the opportunity to work with the xCELLigence to continuously monitor tumor cells infected with our fusogenic oncolytic virus. It will greatly improve our ability to track the morphological changes that occur at very early stages of infection. We are additionally working on a combination of our oncolytic virus platform with TCR T cells and hope to illustrate a synergistic effect in vitro by real time cell analysis with the xCELLigence.”

2017 Grant Recipient


Dr. Karen Wright received the xCELLigence Research Grant to study the role of the CB1 cannabinoid receptor in regulating intercellular tight junctions and permeability in intestinal epithelial cells during inflammation. Though the impact of oxygen concentration on metabolic activity and gene expression profiles has been well established, few cell-based assays attempt to model physiological O2. Working within an enclosed workstation that maintains physiological oxygen concentration, Wright will use the xCELLigence system to monitor both early CB1 receptor signaling events and their long term functional outcome.